[go: up one dir, main page]

NO975811L - Ny anvendelse for pyrrolderivater - Google Patents

Ny anvendelse for pyrrolderivater

Info

Publication number
NO975811L
NO975811L NO975811A NO975811A NO975811L NO 975811 L NO975811 L NO 975811L NO 975811 A NO975811 A NO 975811A NO 975811 A NO975811 A NO 975811A NO 975811 L NO975811 L NO 975811L
Authority
NO
Norway
Prior art keywords
radical
alkyl
pyridyl
branched
hydrogen
Prior art date
Application number
NO975811A
Other languages
English (en)
Other versions
NO975811D0 (no
Inventor
Eric Bacque
Norbert Dereu
Conception Nemecek
Georges Bashiardes
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of NO975811D0 publication Critical patent/NO975811D0/no
Publication of NO975811L publication Critical patent/NO975811L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Bi nye terapeutisk anvendelse for pyrrolderivater med den generelle formel:. der. Het betyr en ring kondensert med pyrrol slik at det dannes en pyrrolotlazol-,. fl) 5,6,7,8-tetrahydro-indolizin-, dlhydro-pyrrolotiazln- eller dihydropyrrolizin-ring,. Ri er en karboksamld-, cyano-, karboksy-, alkyloksykarbonyl-, acyl- eller linldazolylkarbonylrest,. I?2 er et hydrogen- eller halogenatom eller en alkyl-, alkenyl-, trihalogenmetyl- eller cyanorest,. Rer et hydrogen- eller halogenatom eller en hydroksy- eller alkylrest, og. Het' er en pyrldyl-, pyridyl-N-oksyd- eller tlazolylrest,. Idet alkyl- og acylrestene er rette eller forgrenede med 1 til 4 C-atomer og alkenylrestene er rette eller forgrenede med 2 til 4 C-atomer,. samt salter når de eksisterer, for fremstilling av medikamenter ment for behandling av affeksjoner der TNF inngår.
NO975811A 1995-06-14 1997-12-10 Ny anvendelse for pyrrolderivater NO975811L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9507055A FR2735476B1 (fr) 1995-06-14 1995-06-14 Nouvelle application de derives du pyrrole
PCT/FR1996/000887 WO1997000073A1 (fr) 1995-06-14 1996-06-12 Nouvelle application de derives du pyrrole

Publications (2)

Publication Number Publication Date
NO975811D0 NO975811D0 (no) 1997-12-10
NO975811L true NO975811L (no) 1997-12-10

Family

ID=9479965

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975811A NO975811L (no) 1995-06-14 1997-12-10 Ny anvendelse for pyrrolderivater

Country Status (19)

Country Link
US (1) US6194426B1 (no)
EP (1) EP0833635A1 (no)
JP (1) JP2001510437A (no)
KR (1) KR19990022908A (no)
AU (1) AU6309396A (no)
BR (1) BR9609000A (no)
CA (1) CA2221027A1 (no)
CZ (1) CZ400697A3 (no)
EA (1) EA199800057A1 (no)
FR (1) FR2735476B1 (no)
HU (1) HUP9901625A2 (no)
IL (1) IL122560A0 (no)
NO (1) NO975811L (no)
PL (1) PL328669A1 (no)
SK (1) SK171697A3 (no)
TR (1) TR199701604T2 (no)
TW (1) TW336935B (no)
WO (1) WO1997000073A1 (no)
ZA (1) ZA964932B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5871537A (en) 1996-02-13 1999-02-16 Scimed Life Systems, Inc. Endovascular apparatus
FR2757166B1 (fr) * 1996-12-12 1999-01-29 Rhone Poulenc Rorer Sa Derives du pyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2779724B1 (fr) * 1998-06-10 2001-04-20 Rhone Poulenc Rorer Sa Derives du pyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent
US20040014744A1 (en) * 2002-04-05 2004-01-22 Fortuna Haviv Substituted pyridines having antiangiogenic activity
GB0816759D0 (en) * 2008-09-12 2008-10-22 Selcia Ltd Compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931201A (en) * 1974-01-22 1976-01-06 The Dow Chemical Company Substituted pyridinyloxy(thio)phenyl -acetamides, -ureas and urea derivatives
FR2539417A1 (fr) * 1983-01-13 1984-07-20 Rhone Poulenc Sante Nouveaux pyrrolo-1, 2 heterocycles, leur preparation et les medicaments qui les contiennent
FR2557111B1 (fr) 1983-12-21 1986-04-11 Rhone Poulenc Sante Nouveaux derives ortho-condenses du pyrrole, leur preparation et les medicaments qui les contiennent
DK704488D0 (da) * 1988-12-19 1988-12-19 Novo Industri As Nye n-substituerede azaheterocykliske carboxylsyrer
FR2678834A1 (fr) * 1991-07-09 1993-01-15 Rhone Poulenc Rorer Sa Nouvelle application therapeutique du pyridylpyrrolothiazole carboxamide.

Also Published As

Publication number Publication date
CZ400697A3 (cs) 1998-03-18
EA199800057A1 (ru) 1998-10-29
EP0833635A1 (fr) 1998-04-08
FR2735476A1 (fr) 1996-12-20
FR2735476B1 (fr) 1997-07-18
WO1997000073A1 (fr) 1997-01-03
NO975811D0 (no) 1997-12-10
PL328669A1 (en) 1999-02-15
CA2221027A1 (fr) 1997-01-03
JP2001510437A (ja) 2001-07-31
TW336935B (en) 1998-07-21
HUP9901625A2 (hu) 1999-09-28
KR19990022908A (ko) 1999-03-25
AU6309396A (en) 1997-01-15
US6194426B1 (en) 2001-02-27
BR9609000A (pt) 1999-06-29
ZA964932B (en) 1997-01-06
IL122560A0 (en) 1998-06-15
TR199701604T2 (xx) 2000-10-23
MX9709150A (es) 1998-03-31
SK171697A3 (en) 1998-07-08

Similar Documents

Publication Publication Date Title
GB9413975D0 (en) New heterobicyclic derivatives
HUP0100870A2 (hu) Analgetikumokként alkalmazható alfa-amino-amid-származékok
MY118796A (en) 1,2,4-triazolo [4,3-b] pyrido [3,2-d] pyridazine derivatives and pharmaceutical compositions containing them
TNSN06036A1 (en) Pyridyl derivatives and their use as therapeutic agents
MY132872A (en) Benzimidazole derivatives.
NO964871L (no) Nye agonistforbindelser
NO965334D0 (no) Nye 4,6-diarylpyrimidin-derivater og salter derav
CA2093403A1 (en) Therapeutic agent for parkinson's disease
NO20055655L (no) Anvendelse av azetidinkarboksamidderivater i terapi
MXPA04000407A (es) Derivados de fenilacetamido-tiazol, procedimiento para su preparacion y uso como agentes antitumorales.
IE782084L (en) Quinolylguanidine derivatives
NO975811L (no) Ny anvendelse for pyrrolderivater
ATE91128T1 (de) 5,11-dihydro-6h-dipyrido (3,2-b:2',3'-e>diazepin- 6-one und deren verwendung in der vorbeugung und behandlung von aids.
DE69828197D1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
HUP9801751A2 (hu) Benzopiránszármazékok, azok előállítása és alkalmazása, valamint ilyen származékokat tartalmazó gyógyszerkészítmények
NO823125L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2-amino-naftalen-derivater
DE69708484D1 (de) Pyridinderivate,als Arzneimittel zur Behandlung von Geschwüren und als antibakterielle Mittel
EP0742211A4 (en) PYRIDAZINONE DERIVATIVES
CY1106913T1 (el) Προληπτικος παραγων/θεραπευτικος παραγων δια το συνδρομο της φλογωσεως των εντερων που επικρατει της δυσκοιλιοτητος
FI893570A0 (fi) Menetelmä lääkeaineina käyttökelpoisten 1H-imidatso/1,2-b/-pyratsolin johdannaisten valmistamiseksi
JPS56103183A (en) Pyridazine derivative and its application to medicine
ATE220065T1 (de) Benzopyranderivate und ihre verwendung zur behandlung von herzkrankheiten
NO963374L (no) Substituerte 4H-pyraner
EP2266566A3 (en) Nicotinamide derivatives and their use as therapeutic agents
NO970431L (no) Tetrahydroisokinolin-derivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application